Dear Professor Nouri,
We welcome the timely and pragmatic British Medical Laser Association guidance regarding measures needed to resume laser services following COVID-19 lockdown and commend the author for his comprehensive work [1]. Many clinics using laser devices also commonly use electrocautery when undertaking dermatologic surgery which likewise can generate plumes (“surgical smoke”). These plumes are potentially infectious, toxic, and carcinogenic [2]. Surgical plume has been found to harbor particulate pathogens such as coagulase-negative staphylococci, Corynebacterium and Neisseria [3], as well as human papillomavirus [4]. Although there are no reported cases of COVID-19 transmission through the electrocautery plume, the minute size of the particles [5], their high transmissibility [6], and the fact that they have been found in a variety of bodily fluids (including blood, peritoneal fluid [7], and feces [8]) increase the plausibility of finding COVID-19 particles in plumes generated by electrocautery devices [9, 10]. The author suggested use of smoke evacuation devices with various filter devices available [1]. These include charcoal filters (capable of absorbing gas and vapor), high efficiency particulate air filters (filtering particles of greater than 0.3 μm with an efficiency of 99.97%), and ultralow particular air filters (ULPA) (filtering particles of greater than 0.1 μm with an efficiency of 99.99%). A combination of ULPA and charcoal filters is the most effective filtration method [11]. In addition to adopting many of the measures suggested by the author for laser devices [1], including use of personal protective equipment and smoke evacuation devices, practitioners using electrocautery in their clinics may also wish to consider the use of bipolar (rather than unipolar) devices and lower energy settings when using electrocautery devices, both of which are associated with reduced generation of plumes [1].
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Consent for publication
All authors have approved this final submitted version of the manuscript and consent to its submission for consideration of publication.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Madan V. Resumption of laser/IPL skin services post COVID-19 lockdown-British Medical Laser Association (BMLA) guidance document. Lasers Med Sci. 2020;27:1–5. doi: 10.1007/s10103-020-03086-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Searle T, Ali FR, Al-Niaimi F (2020) Surgical plume in dermatology: an insidious and often overlooked hazard. Clin Exp Dermatol. 10.1111/ced.14350 [DOI] [PMC free article] [PubMed]
- 3.Capizzi PJ, Clay RP, Battey MJ. Microbiologic activity in laser resurfacing plume and debris. Lasers Surg Med. 1998;23(3):172–174. doi: 10.1002/(SICI)1096-9101(1998)23:3<172::AID-LSM7>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
- 4.Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM. Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection. J Am Acad Dermatol. 1989;21(1):41–49. doi: 10.1016/S0190-9622(89)70146-8. [DOI] [PubMed] [Google Scholar]
- 5.Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;20:676–680. doi: 10.1038/s41591-020-0843-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Coccolini F, Tartaglia D, Puglisi A et al (2020) SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients. Ann Surg. Available at: https://journals.lww.com/annalsofsurgery/Documents/SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients.pdf (accessed 14 August 2020) [DOI] [PMC free article] [PubMed]
- 8.Wu Y, Guo C, Tang L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. 2020;5:434–435. doi: 10.1016/S2468-1253(20)30083-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mowbray NG, Ansell J, Horwood J, et al. Safe management of surgical smoke in the age of COVID-19. Br J Surg. 2020;107(11):1406–1413. doi: 10.1002/bjs.11679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Mintz Y, Arezzo A, Boni L, et al. The risk of COVID-19 transmission by laparoscopic smoke may be lower than for laparotomy: a narrative review. Surg Endosc. 2020;34(8):3298–3305. doi: 10.1007/s00464-020-07652-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Katoch S, Mysore V. Surgical smoke in dermatology: its hazards and management. J Cutan Aesthet Surg. 2019;12(1):1–7. doi: 10.4103/JCAS.JCAS_177_18. [DOI] [PMC free article] [PubMed] [Google Scholar]